Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?

Imatinib plasma trough concentrations are associated with efficacy for patients treated for advanced or metastatic KIT-positive gastrointestinal stromal tumours (GISTs). This relationship has not been studied for patients treated in the neoadjuvant setting, let alone its correlation with tumour drug...

Full description

Bibliographic Details
Main Authors:	Eline L. Giraud, Loek A. W. de Jong, Erik van den Hombergh, Suzanne E. J. Kaal, Nielka P. van Erp, Ingrid M. E. Desar
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Cancers
Subjects:	imatinib neoadjuvant treatment gastrointestinal stromal tumours GIST tyrosine kinase inhibitors tumour drug concentrations
Online Access:	https://www.mdpi.com/2072-6694/15/11/2875

Similar Items

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
by: Thanaporn Bussabawalai, et al.
Published: (2019-01-01)

A ruptured gastrointestinal stromal tumour of the small intestine: a case report
by: Ivan Lolli, et al.
Published: (2015-10-01)

Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
by: Fousséni Alassani, et al.
Published: (2019-11-01)

Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
by: Macías-García Laura, et al.
Published: (2012-10-01)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)

A gist on an obscure neoplasm in Ghana: gastrointestinal stromal tumours
by: Joseph Yorke, et al.
Published: (2023-11-01)

Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib
by: Qu H, et al.
Published: (2022-03-01)

Management of gastrointestinal stromal tumors: from diagnosis to treatment
by: JF Egger
Published: (2004-03-01)

Polekowe zapalenie skóry wywołane imatynibem u pacjentki z nowotworem podścieliska przewodu pokarmowego – opis przypadku
by: Hanna Myśliwiec, et al.
Published: (2011-07-01)

Synchronous well differentiated neuroendocrine tumour and gastrointestinal stromal tumour of the stomach: a case report
by: Machairas Anastasios, et al.
Published: (2011-03-01)

Gastrointestinal Stromal Tumours: A Review on Genetics, Pathology, Risk Stratification, Clinical Characteristics, Investigation, and Treatment
by: Md Tanveer Adil, et al.
Published: (2016-11-01)

Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour
by: Michael C. Onyema, et al.
Published: (2020-07-01)

Gastrointestinal stromal tumours in patients presenting to an academic hospital in South Africa
by: Barbara M. Robertson, et al.
Published: (2023-06-01)

Case report: Desmoid fibromatosis diagnosed in a 27-year-old male after being mistaken for a gastrointestinal stromal tumour
by: Larissa Albino, et al.
Published: (2022-11-01)

Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
by: Nikolaos Vassos, et al.
Published: (2021-02-01)

Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01)

Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
by: Szymon Macioszek, et al.
Published: (2023-04-01)

Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour
by: Alexandre Bertucci, et al.
Published: (2019-08-01)

The concurrent occurrence of neuroendocrine tumour and gastrointestinal stromal tumours
by: Divya Rathod, et al.
Published: (2022-10-01)

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours
by: Juan Liu, et al.
Published: (2022-04-01)

Gastrointestinal Stromal Tumours (GIST) of the Rectum: A Systematic Review and Meta-Analysis
by: Shaheer I. Khan, et al.
Published: (2022-12-01)

Gastrointestinal Stromal Tumour with Liver Metastasis Presenting as Gastric Cancer
by: Yongwei Xu, et al.
Published: (2023-01-01)

Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib
by: Chien-Yang Wang, et al.
Published: (2018-01-01)

Double hit: Synchronous gastrointestinal stromal tumour (GIST) & lung neuroendocrine tumour − a rare case of multiple primary malignancies
by: Kadli Shirish Kumar, et al.
Published: (2021-01-01)

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
by: Maria A. Pantaleo, et al.
Published: (2022-05-01)

Conjunctival stromal tumour: A case report
by: Jane E. Buys, et al.
Published: (2024-03-01)

Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours
by: Marin Golčić, et al.
Published: (2023-08-01)

A traumatic means of diagnosing gastrointestinal stromal tumour: A case report
by: M Tun, et al.
Published: (2022-11-01)

Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010
by: Lucia Tozzi
Published: (2015-10-01)

Spontaneous Perforation as a First Presentation of Ileal Gastrointestinal Stromal Tumour (GIST) with Synchronous Breast Sarcoma
by: Bir Kumar Sharma M., et al.
Published: (2014-05-01)

Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation
by: J Hislop, et al.
Published: (2011-06-01)

Diagnosis and management of high risk gastrointestinal stromal tumor in first trimester pregnancy: A case report and review of the literature
by: Christina M. Sheedy, et al.
Published: (2023-05-01)

Transanal minimally invasive surgery (TAMIS) approach for large juxta-anal gastrointestinal stromal tumour
by: Nicolas Wachter, et al.
Published: (2016-01-01)

Precision Oncology in Gastrointestinal Stromal Tumors
by: Hiba Mechahougui, et al.
Published: (2023-04-01)

Type and Gene Location of <i>KIT</i> Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon
by: Lorena Incorvaia, et al.
Published: (2021-02-01)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018-03-01)

Mesenteric desmoid tumor developing on the site of an excised gastrointestinal stromal tumor
by: Kevin Wedgwood, et al.
Published: (2010-06-01)

Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
by: Lei Cao, et al.
Published: (2022-05-01)

Surgical Approaches and Oncological Outcomes in the Management of Duodenal Gastrointestinal Stromal Tumors (GIST)
by: Nikolaos Vassos, et al.
Published: (2021-09-01)

Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
by: Cristina Arqueros, et al.
Published: (2024-02-01)